- OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET
- OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023
- OptimizeRx Powers Walmart's ‘Specialty Pharmacies of the Community’ Outreach Effort
- OptimizeRx to Participate in Upcoming Investor Conferences
- OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape
- OptimizeRx Preannounces Select Expected 2023 Financials and Provides a Business Update
- OptimizeRx to Participate at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco
- OptimizeRx Reports Third Quarter 2023 Financial Results
- OptimizeRx Announces Completion of Medicx Acquisition and Sets Third Quarter 2023 Conference Call for November 6, 2023, at 8:30 a.m. ET
- OptimizeRx Announces Agreement to Acquire Medicx Health for $95 million to Expand its Omnichannel Reach to Consumers
More ▼
Key statistics
On Thursday, OPTIMIZERx Corp (OPRX:NAQ) closed at 12.15, -27.01% below its 52-week high of 16.65, set on Mar 08, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 11.78 |
---|---|
High | 12.40 |
Low | 11.65 |
Bid | 4.87 |
Offer | 12.36 |
Previous close | 12.15 |
Average volume | 185.41k |
---|---|
Shares outstanding | 18.15m |
Free float | 16.00m |
P/E (TTM) | -- |
Market cap | 220.55m USD |
EPS (TTM) | -0.8104 USD |
Data delayed at least 15 minutes, as of Mar 28 2024 20:00 BST.
More ▼